---
schema_version: "secwatch.filing_event.v1"
accession: "0001588978-23-000019"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T00:31:19.437158+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PROCEPT BioRobotics Q2 revenue $33.1M (+98% YoY); raises FY2023 guidance to $131M

## Summary
- Record 40 U.S. AquaBeam systems sold in Q2; U.S. system revenue $14.8M (+74% YoY).
- U.S. handpiece & consumables revenue $13.6M (+138% YoY); utilization per account up 9%.
- Gross margin 56% (vs 51% prior year); narrowed net loss $25.3M vs $19.2M.
- FY2023 revenue guidance raised to $131M (from $128M); gross margin ~55% (from ~54%).
- United Healthcare issued positive coverage policy for Aquablation, effective June 1, 2023.

## SEC filing metadata
- accession: 0001588978-23-000019
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/prct-20230727.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001588978-23-000019
- JSON: https://secwatch.observer/filing/0001588978-23-000019.json
- Plain text: https://secwatch.observer/filing/0001588978-23-000019.txt

## Key facts
- Earnings Releases
  PROCEPT BioRobotics Corp reported quarter ended June 30, 2023 results: net income -$25.3 million.
  - Period: quarter ended June 30, 2023
  - Net income: -$25.3 million
  - Result: reported results
  source text: Total revenue for the second quarter of 2023 was $33.1 million, an increase of 98% compared to the prior year period.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm
- Earnings Releases
  PROCEPT BioRobotics Corp reported quarter ended June 30, 2023 results: net income -$25.3 million.
  - Period: quarter ended June 30, 2023
  - Net income: -$25.3 million
  - Result: reported results
  source text: Net loss was $25.3 million for the second quarter of 2023, compared to a loss of $19.2 million in the prior year period.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm
- Earnings Releases
  PROCEPT BioRobotics Corp reported full year 2023 results: revenue $131 million. Guidance raised.
  - Period: full year 2023
  - Revenue: $131 million
  - Guidance: raised
  - Result: guidance update
  source text: The Company projects revenue for the full year 2023 to be approximately $131 million, which represents 75% growth over the Company’s prior year revenue. This compares to previous revenue guidance of $128 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.